Pazdan Christopher 4

What Happened Christopher Pazdan, Chief Operating Officer of KORU Medical Systems, reported a purchase of 5,000 common shares on May 14, 2026. The reported price was $3.88 per share, for a total transaction value of $19,400. The Form 4 classifies the trade as a purchase (code P) — an acquisition rather than a sale.

Key Details

• Transaction date: 2026-05-14
• Transaction type: Open market or private purchase (Form 4 code P)
• Price per share: $3.88; Total value: $19,400
• Shares owned following the transaction: Not specified in the information provided in this summary (not included in the details you supplied).
• Filing date: 2026-05-18 — filed within the standard two business days after the trade (timely).
• Remarks on the filing: Includes standard disclaimer that the filing is not an admission of beneficial ownership; a Power of Attorney has been previously filed.

Context

• Purchases by corporate officers are often watched by investors as a potential positive signal, but this summary is factual only and does not infer motivations.
• The purchase size ($19.4k) is relatively modest compared with many insider trades; retail investors may consider it alongside other insider activity and company fundamentals.